Firefly Neuroscience, Inc.
AIFF
$2.24
$0.2613.13%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 677.36% | 1,075.76% | 2,890.00% | 258.33% | 178.95% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 677.36% | 1,075.76% | 2,890.00% | 258.33% | 178.95% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 243.40% | 342.42% | 2,640.00% | 258.33% | 178.95% |
| SG&A Expenses | -2.30% | -35.09% | 65.61% | 120.64% | 39.88% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.61% | -33.92% | 48.38% | 91.12% | 64.88% |
| Operating Income | 6.25% | 42.50% | -25.81% | -89.28% | -63.50% |
| Income Before Tax | 34.47% | 38.47% | -44.70% | -1,052.41% | -251.58% |
| Income Tax Expenses | -50.00% | -- | -- | -- | 100.00% |
| Earnings from Continuing Operations | 34.48% | 38.47% | -45.02% | -1,052.41% | -251.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 34.48% | 38.47% | -45.02% | -1,052.41% | -251.44% |
| EBIT | 6.25% | 42.50% | -25.81% | -89.28% | -63.50% |
| EBITDA | 7.35% | 43.39% | -26.01% | -- | -63.61% |
| EPS Basic | 54.06% | 67.72% | 40.53% | -706.25% | -48.73% |
| Normalized Basic EPS | 47.68% | 70.21% | 42.27% | -501.19% | -14.40% |
| EPS Diluted | 54.06% | 67.72% | 40.53% | -706.25% | -48.73% |
| Normalized Diluted EPS | 47.68% | 70.21% | 42.27% | -501.19% | -14.40% |
| Average Basic Shares Outstanding | 56.40% | 90.62% | 143.88% | 91.67% | 136.27% |
| Average Diluted Shares Outstanding | 56.40% | 90.62% | 143.88% | 91.67% | 136.27% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |